Acquisition of a side population fraction augments malignant phenotype in ovarian cancer

Abstract Side population (SP) cells harbor malignant phenotypes in cancer. The aim of this study was to identify genes that modulate the proportion of ovarian cancer SP cells. Using a shRNA library targeting 15,000 genes, a functional genomics screen was performed to identify genes whose suppression...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Koji Yamanoi, Tsukasa Baba, Kaoru Abiko, Junzo Hamanishi, Ken Yamaguchi, Ryusuke Murakami, Mana Taki, Yuko Hosoe, Susan K. Murphy, Ikuo Konishi, Masaki Mandai, Noriomi Matsumura
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
R
Q
Acceso en línea:https://doaj.org/article/44e8b3ffbba9498a88db3b0789ca4998
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:44e8b3ffbba9498a88db3b0789ca4998
record_format dspace
spelling oai:doaj.org-article:44e8b3ffbba9498a88db3b0789ca49982021-12-02T15:08:47ZAcquisition of a side population fraction augments malignant phenotype in ovarian cancer10.1038/s41598-019-50794-w2045-2322https://doaj.org/article/44e8b3ffbba9498a88db3b0789ca49982019-10-01T00:00:00Zhttps://doi.org/10.1038/s41598-019-50794-whttps://doaj.org/toc/2045-2322Abstract Side population (SP) cells harbor malignant phenotypes in cancer. The aim of this study was to identify genes that modulate the proportion of ovarian cancer SP cells. Using a shRNA library targeting 15,000 genes, a functional genomics screen was performed to identify genes whose suppression increased the SP percentage. The biological effects caused by alteration of those identified genes were investigated in vitro and in vivo. We found that suppression of MSL3, ZNF691, VPS45, ITGB3BP, TLE2, and ZNF498 increased the proportion of SP cells. Newly generated SP cells exhibit greater capacity for sphere formation, single cell clonogenicity, and in vivo tumorigenicity. On the contrary, overexpression of MSL3, VPS45, ITGB3BP, TLE2, and ZNF498 decreased the proportion of SP cells, sphere formation capacity and single cell clonogenicity. In ovarian cancer cases, low expression of MSL3, ZNF691 and VPS45 was related to poor prognosis. Suppression of these six genes enhanced activity of the hedgehog pathway. Cyclopamine, a hedgehog pathway inhibitor, significantly decreased the number of SP cells and their sphere forming ability. Our results provide new information regarding molecular mechanisms favoring SP cells and suggest that Hedgehog signaling may provide a viable target for ovarian cancer.Koji YamanoiTsukasa BabaKaoru AbikoJunzo HamanishiKen YamaguchiRyusuke MurakamiMana TakiYuko HosoeSusan K. MurphyIkuo KonishiMasaki MandaiNoriomi MatsumuraNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 9, Iss 1, Pp 1-13 (2019)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Koji Yamanoi
Tsukasa Baba
Kaoru Abiko
Junzo Hamanishi
Ken Yamaguchi
Ryusuke Murakami
Mana Taki
Yuko Hosoe
Susan K. Murphy
Ikuo Konishi
Masaki Mandai
Noriomi Matsumura
Acquisition of a side population fraction augments malignant phenotype in ovarian cancer
description Abstract Side population (SP) cells harbor malignant phenotypes in cancer. The aim of this study was to identify genes that modulate the proportion of ovarian cancer SP cells. Using a shRNA library targeting 15,000 genes, a functional genomics screen was performed to identify genes whose suppression increased the SP percentage. The biological effects caused by alteration of those identified genes were investigated in vitro and in vivo. We found that suppression of MSL3, ZNF691, VPS45, ITGB3BP, TLE2, and ZNF498 increased the proportion of SP cells. Newly generated SP cells exhibit greater capacity for sphere formation, single cell clonogenicity, and in vivo tumorigenicity. On the contrary, overexpression of MSL3, VPS45, ITGB3BP, TLE2, and ZNF498 decreased the proportion of SP cells, sphere formation capacity and single cell clonogenicity. In ovarian cancer cases, low expression of MSL3, ZNF691 and VPS45 was related to poor prognosis. Suppression of these six genes enhanced activity of the hedgehog pathway. Cyclopamine, a hedgehog pathway inhibitor, significantly decreased the number of SP cells and their sphere forming ability. Our results provide new information regarding molecular mechanisms favoring SP cells and suggest that Hedgehog signaling may provide a viable target for ovarian cancer.
format article
author Koji Yamanoi
Tsukasa Baba
Kaoru Abiko
Junzo Hamanishi
Ken Yamaguchi
Ryusuke Murakami
Mana Taki
Yuko Hosoe
Susan K. Murphy
Ikuo Konishi
Masaki Mandai
Noriomi Matsumura
author_facet Koji Yamanoi
Tsukasa Baba
Kaoru Abiko
Junzo Hamanishi
Ken Yamaguchi
Ryusuke Murakami
Mana Taki
Yuko Hosoe
Susan K. Murphy
Ikuo Konishi
Masaki Mandai
Noriomi Matsumura
author_sort Koji Yamanoi
title Acquisition of a side population fraction augments malignant phenotype in ovarian cancer
title_short Acquisition of a side population fraction augments malignant phenotype in ovarian cancer
title_full Acquisition of a side population fraction augments malignant phenotype in ovarian cancer
title_fullStr Acquisition of a side population fraction augments malignant phenotype in ovarian cancer
title_full_unstemmed Acquisition of a side population fraction augments malignant phenotype in ovarian cancer
title_sort acquisition of a side population fraction augments malignant phenotype in ovarian cancer
publisher Nature Portfolio
publishDate 2019
url https://doaj.org/article/44e8b3ffbba9498a88db3b0789ca4998
work_keys_str_mv AT kojiyamanoi acquisitionofasidepopulationfractionaugmentsmalignantphenotypeinovariancancer
AT tsukasababa acquisitionofasidepopulationfractionaugmentsmalignantphenotypeinovariancancer
AT kaoruabiko acquisitionofasidepopulationfractionaugmentsmalignantphenotypeinovariancancer
AT junzohamanishi acquisitionofasidepopulationfractionaugmentsmalignantphenotypeinovariancancer
AT kenyamaguchi acquisitionofasidepopulationfractionaugmentsmalignantphenotypeinovariancancer
AT ryusukemurakami acquisitionofasidepopulationfractionaugmentsmalignantphenotypeinovariancancer
AT manataki acquisitionofasidepopulationfractionaugmentsmalignantphenotypeinovariancancer
AT yukohosoe acquisitionofasidepopulationfractionaugmentsmalignantphenotypeinovariancancer
AT susankmurphy acquisitionofasidepopulationfractionaugmentsmalignantphenotypeinovariancancer
AT ikuokonishi acquisitionofasidepopulationfractionaugmentsmalignantphenotypeinovariancancer
AT masakimandai acquisitionofasidepopulationfractionaugmentsmalignantphenotypeinovariancancer
AT noriomimatsumura acquisitionofasidepopulationfractionaugmentsmalignantphenotypeinovariancancer
_version_ 1718387994280329216